AU520543B2 - Surface active material - Google Patents

Surface active material

Info

Publication number
AU520543B2
AU520543B2 AU58678/80A AU5867880A AU520543B2 AU 520543 B2 AU520543 B2 AU 520543B2 AU 58678/80 A AU58678/80 A AU 58678/80A AU 5867880 A AU5867880 A AU 5867880A AU 520543 B2 AU520543 B2 AU 520543B2
Authority
AU
Australia
Prior art keywords
active material
surface active
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU58678/80A
Other languages
English (en)
Other versions
AU5867880A (en
Inventor
Fujiwara Tetsuro
Takei Tsunetomo
Tanaka Yuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13367224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU520543(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of AU5867880A publication Critical patent/AU5867880A/en
Application granted granted Critical
Publication of AU520543B2 publication Critical patent/AU520543B2/en
Assigned to TT PHARMACEUTICALS, INC. reassignment TT PHARMACEUTICALS, INC. Alteration of Name(s) in Register under S187 Assignors: TOKYO TANABE COMPANY LIMITED
Assigned to MITSUBISHI-TOKYO PHARMACEUTICALS, INC. reassignment MITSUBISHI-TOKYO PHARMACEUTICALS, INC. Request to Amend Deed and Register Assignors: TT PHARMACEUTICALS, INC.
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
AU58678/80A 1979-06-02 1980-05-22 Surface active material Expired AU520543B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6821179A JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
JP6821179 1979-06-02

Publications (2)

Publication Number Publication Date
AU5867880A AU5867880A (en) 1981-12-10
AU520543B2 true AU520543B2 (en) 1982-02-04

Family

ID=13367224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58678/80A Expired AU520543B2 (en) 1979-06-02 1980-05-22 Surface active material

Country Status (8)

Country Link
US (1) US4338301A (enExample)
JP (1) JPS55160721A (enExample)
AU (1) AU520543B2 (enExample)
CA (1) CA1161754A (enExample)
DE (1) DE3021006C2 (enExample)
FR (1) FR2457872A1 (enExample)
GB (1) GB2050832B (enExample)
MX (1) MX9203482A (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
DD225841C2 (de) * 1983-12-08 1986-04-16 Dresden Arzneimittel Verfahren zur herstellung eines mittels zur behandlung von erkrankungen, die mit veraenderungen des pulmonalen surfactant-systems einhergehen
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
FR2559669B1 (fr) * 1984-02-20 1986-05-09 Nabavi Seyfeddine Lipoproteine haute densite cholesterol synthetique
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
EP0904295B1 (en) * 1996-05-15 2005-08-10 ALTANA Pharma AG Process for separating and analyzing hydrophobic proteins using thin layer chromatography
US6855342B2 (en) * 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
US6514489B1 (en) 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin

Also Published As

Publication number Publication date
AU5867880A (en) 1981-12-10
FR2457872A1 (fr) 1980-12-26
FR2457872B1 (enExample) 1984-09-21
DE3021006C2 (de) 1983-03-17
MX9203482A (es) 1992-08-01
JPS55160721A (en) 1980-12-13
GB2050832A (en) 1981-01-14
DE3021006A1 (de) 1981-01-08
CA1161754A (en) 1984-02-07
GB2050832B (en) 1983-08-03
US4338301A (en) 1982-07-06
JPS619925B2 (enExample) 1986-03-27

Similar Documents

Publication Publication Date Title
AU520543B2 (en) Surface active material
AU518775B2 (en) Elastomeric material covered rolls
AU544333B2 (en) Shaped materials
AU530321B2 (en) Absorbent material
AU532905B2 (en) Contact lens material
AU520186B2 (en) Sheet material
AU533929B2 (en) Decorative material
AU532376B2 (en) Friction material
AU5741480A (en) Penetrometer
AU524336B2 (en) Filling material
AU532106B2 (en) p
AU538342B2 (en) Surface stabilising material
AU533304B2 (en) Bearing material
AU539878B2 (en) Sliding material
AU535681B2 (en) Dry-image forming material
AU543085B2 (en) Oligopeptide composition
AU5661180A (en) Backfill material
GB2039868B (en) Bismuth-germanium-oxide material
AU523736B2 (en) Discontinouosly holding cotton-like material
AU5474980A (en) Trifluorethylated oligopeptides
SU679769A1 (ru) Оберточный материал
AU534572B2 (en) 6b-(2-(2:-methylphenorgcarbonyl)-2-thien-3:-ylacetamido)
JPS55145798A (en) Surface active agent
AU530788B2 (en) Radiation-sensitive material
AU5370679A (en) Clay based absorbent material

Legal Events

Date Code Title Description
HB Alteration of name in register

Free format text: MITSUBISHI-TOKYO PHARMACEUTICALS, INC.